ID: ALA362707

Max Phase: Preclinical

Molecular Formula: C21H26N2

Molecular Weight: 306.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCN2CC1CCC2C(c1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C21H26N2/c1-22-14-15-23-16-19(22)12-13-20(23)21(17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,19-21H,12-16H2,1H3

Standard InChI Key:  HTKSURFDHVRPON-UHFFFAOYSA-N

Associated Targets(non-human)

Monoamine transporters; Norepininephrine & dopamine 561 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine transporter 6071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin transporter 6087 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Norepinephrine transporter 2222 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Monoamine transporters; serotonin & dopamine 1148 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.45Molecular Weight (Monoisotopic): 306.2096AlogP: 3.60#Rotatable Bonds: 3
Polar Surface Area: 6.48Molecular Species: BASEHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.12CX LogP: 4.07CX LogD: 2.35
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.85Np Likeness Score: 0.02

References

1. Kolhatkar R, Cook CD, Ghorai SK, Deschamps J, Beardsley PM, Reith ME, Dutta AK..  (2004)  Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.,  47  (21): [PMID:15456254] [10.1021/jm049796t]

Source